alexa Induced Pluripotent Stem Cells Restore Function in a Hu
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma

Abu-Hassan DW, Li X, Ryan EP, Acott TS and Kelley MJ*
Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States
Corresponding Author : Mary Jane Kelley
Ph. D, Associate Professor of Ophthalmology, Casey Eye Institute
Oregon Health and Science University Ophthalmology
3181 SW Sam Jackson Park Road, LBRB-L467AD, United States
Portland, Oregon 97239, United states
Tel: 1-503-494-3594
E-mail: [email protected]
Received date: February 09, 2016; Accepted date: March 26, 2016; Published date: March 31, 2016
Citation: Abu-Hassan DW, Li X, Ryan EP, Acott TS, Kelley MJ (2016) Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma. J Clin Exp Ophthalmol 7:535. doi:10.4172/2155-9570.1000535
Copyright: © 2016 Abu-Hassan DW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




The possibilities of novel stem cell therapies to curtail treat, or even cure diseases are enticing, yet safety and functional questions remain prior to clinical use. Currently the stem cell transplantation field for eye diseases is generally defined as being at the pre-clinical or early clinical trials stages. Pre-clinical studies can hopefully eliminate or determine possible transplantation complications prior to human trials. In our manuscript in Stem Cells, we investigated the possibilities of using a personalized cell therapy to treat glaucoma, and in this paper reported two crucial breakthroughs towards this end.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version